4 Green Flags For Jazz Pharmaceuticals’ Buyout of GW Pharmaceuticals

Pot investors are hardly strangers to splashy mergers and acquisitions. And following the big news about Aphria and Tilray combining their companies, there’s a new deal that’s making waves in the cannabis sector. On Wednesday, Jazz Pharmaceuticals (NASDAQ: JAZZ) announced it’s buRead MoreMarketsMarkets Feed

¡Haz clic para votar esta entrada!
(Votos: 0 Promedio: 0)

Deja un comentario